new insights into the pathophysiology of rheumatic valve disease based on different genetic and proteomics profiles.

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Ana Cecilia Almeida Valadares

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)

4 More presentations in this session

Presentation thumbnail

Subendocardial ischemic-like state in patients with severe aortic stenosis: insights from myocardial histopathology and ultrastructure.

Doctor R. Reis Santos (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

Causal association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis

Doctor W. Nie (Beijing, CN)

Abstract Slides Video

Presentation thumbnail

The effect of the LPA gene on aortic valve calcification in a Portuguese population

Doctor F. Sousa (Funchal, PT)

Abstract Slides Video

Presentation thumbnail

Polymorphic size of Lipoprotein (a) and structural bioprosthetic valve degeneration

Doctor R. Capoulade (Nantes, FR)

Abstract Slides Video

Access the full session

Session thumbnail

Unravelling the pathophysiology of valvular heart disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

Feasibility and midterm outcomes of mitral valve repair in rheumatic heart disease: a multicenter study with multimodal imaging insights

Congress Presentation

Glycolysis blockade reduces synthesis and maturation of glycoproteins as well as leukocyte adhesion in inflamed aortic valve cells

Congress Presentation

Natural progression of rheumatic aortic valve disease following rheumatic mitral valve intervention: 16-year single center experience

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources